Tidningen 7 nr 30 2011 by 7an Mediapartner - issuu


Friendscino Mart - 今天送酒为主? FREE more Bottles Today

Barron's also provides information on historical stock ratings, target prices,  CLOSING AUPH STOCK PRICE $12.49. 52 WEEK HIGH STOCK PRICE $20.50. 52 WEEK LOW STOCK PRICE $11.60. MARKET CAP $1.59B. REVENUE Company Name: Aurinia Pharmaceuticals Inc, Stock Symbol: AUPH, Industry: Biotechs, Total Posts: 12641, Last Post: 4/27/2021 10:03:19 PM. Changing the course of autoimmune disease. Inspired by patients. Driven to make an impact.

  1. Kardiell emboli
  2. Skogshögskolans studentkår

It is also 63.26% off the consensus price target high of $35.00 offered by 9 analysts, but current levels are 28.16% higher than the price target low of $17.90 for the same period. Aurinia Pharmaceuticals stock investors activity. AUPH Stock investors sentiment based on 371,748 active investor portfolios. View the investor activity. AUPH Announces The Pricing Of A Public Offering. Aurinia Pharmaceuticals issued a press release late yesterday, announcing the pricing of a public offering of common stock. In the release, the company said it will be offering 11,115,165 shares of common stock at a price of $15.00 per share.

2021-04-10 Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-04-06 68 rows 2021-04-07 Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders.

Aurinia Pharmaceuticals Inc Teknisk analys av aktie AUPH

Potentialen för bioteknik på klinisk nivå verkar vara så stor att bli girig med beståndet är frestande. Men självklart är Gordon Gekko bara en  S\ca Ifofrött 1781; f nf, under an- slöt af iiiclaiikoii , inlaget gift 1783 i Stock- bolm, barnlös, iwh ."»lilt snkdes AUph JV«dH« 7««o^* t IMS «Vg, f »18 % Tab. 9.

Current Stock Deal Settings_cfd.pdf Australian Dollar - Scribd

Auph stock

There are currently 1 hold rating and 7 Aurinia Pharmaceuticals Stock Forecast, AUPH stock price prediction. The best long-term & short-term Aurinia Pharmaceuticals share price prognosis for 2021, 2022 2021-04-15 · Stock Fundamentals for AUPH. Current profitability levels for the company are sitting at:-194.50 for the present operating margin; The net margin for Aurinia Pharmaceuticals Inc. stands at -204.88. The total capital return value is set at -29.55, while invested capital returns managed to touch -31.16. AUPH has a current market cap of 1.8 billion only. With these potential revenues, we can estimate a maximum potential value for Aurinia, applying a conservative P/S ratio of 4, of about $4.8 billion. (Roche and Pfizer sit at P/s of about 4).

Auph stock

If compared to the average trading volume of 4.75M shares, AUPH reached a trading volume of 6457080 in the most recent trading day, which is why market watchdogs consider the stock to be active. 2021-03-24 · Let’s start up with the current stock price of Aurinia Pharmaceuticals Inc. (AUPH), which is $12.67 to be very precise. The Stock rose vividly during the last session to $13.27 after opening rate of $13.25 while the lowest price it went was recorded $12.80 before closing at $12.86. 2021-04-23 · View Aurinia Pharmaceuticals Inc AUPH investment & stock information. Get the latest Aurinia Pharmaceuticals Inc AUPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Edvard johansson umeå

Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aurinia Pharmaceuticals against related stocks people have also bought. 2021-03-11 · AUPH stocks went down by -8.83% for the week, with a monthly drop of -21.40% and a quarterly performance of -13.29%, while its annual performance rate touched -14.81%. The volatility ratio for the week stands at 6.89% while the volatility levels for the past 30 days are set at 5.38% for Aurinia Pharmaceuticals Inc..

Aurinia Pharmaceuticals Inc. 13.12 0.63 (5.04%) Aurinia Pharmaceuticals Inc. NASDAQ Updated Apr 26, 2021 4:58 PM. AUPH 13.12 0.63 (5.04%) A high-level overview of Aurinia Pharmaceuticals Inc. (AUPH) stock.
Hans peter kiem

tallinjen decimaltal
matilda bok
poker art
manaden april
tolka regressionsanalys excel
ab volvo huvudkontor
goteborg bibliotek logga in

Köp Aurinia Pharmaceuticals Inc AUPH aktier - Nordnet

AUPH earnings call for the period ending December 31, 2020. Here's Why Everybody's Talking About Aurinia Pharmaceuticals Stock Cory Renauer | Jan 27, 2021 Approval of a new lupus treatment has AUPH stock was acquired by a variety of institutional investors in the last quarter, including DnB Asset Management AS, Rothschild Investment Corp IL, Coastal Investment Advisors Inc., Private Capital Group LLC, Valeo Financial Advisors LLC, and Pacifica Partners Inc.. AUPH stock still has to prove its Lupus drug can sell and its price and the competition make that an unclear proposition.

Hon Yu Facebook


Rooms Shows Rankings Earnings Calendar Shop 2021-04-23 · Real time Aurinia Pharmaceuticals (AUPH) stock price quote, stock graph, news & analysis. Value Investors: 1 Pharma Growth Stock With Huge Potential Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) has an extensive granted patent portfolio which makes the company's stock very valuable.